Free-cash-flow proxy increased 638.1%
Free-cash-flow proxy changed +638.1% from the comparable as-filed period.
$733.0M→$5.4B2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →GEV financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow increased 518.1%
Operating cash flow changed +518.1% from the comparable as-filed period.
$980.0M→$6.1B2 prior comparisons
Operating income increased 280.9%
Operating income changed +280.9% from the comparable as-filed period.
$366.0M→$1.4B2 prior comparisons
Operating margin moved 736 bp higher
Operating margin changed +736 basis points from the comparable as-filed period.
3.67%→11.03%2 prior comparisons
Gross margin moved 555 bp higher
Gross margin changed +555 basis points from the comparable as-filed period.
19.03%→24.58%2 prior comparisons
Net income increased 185.6%
Net income changed +185.6% from the comparable as-filed period.
$452.0M→$1.3B2 prior comparisons
Revenue increased 26.8%
Revenue changed +26.8% from the comparable as-filed period.
$10.0B→$12.6B2 prior comparisons
Shares outstanding decreased 2.4%
Shares outstanding changed -2.4% from the comparable as-filed period. The change ranks at the 100th percentile of 5 prior comparable changes.
271,320,459→264,677,0665 prior comparisons
Total assets increased 58.5%
Total assets changed +58.5% from the comparable as-filed period.
$54.4B→$86.2B3 prior comparisons
Current liabilities increased 77.1%
Current liabilities changed +77.1% from the comparable as-filed period.
$35.3B→$62.5B3 prior comparisons
Current assets increased 42.5%
Current assets changed +42.5% from the comparable as-filed period.
$36.3B→$51.7B3 prior comparisons
Inventory increased 30.0%
Inventory changed +30.0% from the comparable as-filed period.
$10.0B→$13.0B3 prior comparisons
Gross profit increased 63.8%
Gross profit changed +63.8% from the comparable as-filed period.
$1.9B→$3.1B2 prior comparisons
Capex / revenue moved 264 bp higher
Capex / revenue changed +264 basis points from the comparable as-filed period.
2.48%→5.12%2 prior comparisons
Capital expenditure increased 161.9%
Capital expenditure changed +161.9% from the comparable as-filed period.
$247.0M→$647.0M2 prior comparisons
Inventory / revenue moved 256 bp higher
Inventory / revenue changed +256 basis points from the comparable as-filed period.
100.63%→103.19%2 prior comparisons
Working capital / assets moved 1436 bp lower
Working capital / assets changed -1436 basis points from the comparable as-filed period.
1.85%→-12.51%3 prior comparisons
Free-cash-flow margin moved 3544 bp higher
Free-cash-flow margin changed +3544 basis points from the comparable as-filed period.
7.35%→42.79%2 prior comparisons
Operating cash-flow margin moved 3808 bp higher
Operating cash-flow margin changed +3808 basis points from the comparable as-filed period.
9.83%→47.91%2 prior comparisons
Cost of revenue increased 18.2%
Cost of revenue changed +18.2% from the comparable as-filed period.
$8.1B→$9.5B2 prior comparisons
Operating cash flow / net income increased 116.4%
Operating cash flow / net income changed +116.4% from the comparable as-filed period.
2.17→4.691 prior comparisons
Research & development increased 15.5%
Research & development changed +15.5% from the comparable as-filed period.
$310.0M→$358.0M2 prior comparisons
Working capital changed across a sign change
Working capital changed -1172.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$1.0B→-$10.8B3 prior comparisons
Current ratio decreased 19.6%
Current ratio changed -19.6% from the comparable as-filed period.
1.03→0.833 prior comparisons
Selling, general & administrative increased 10.9%
Selling, general & administrative changed +10.9% from the comparable as-filed period.
$1.2B→$1.4B2 prior comparisons
R&D / revenue moved 28 bp lower
R&D / revenue changed -28 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
3.11%→2.83%2 prior comparisons
Operating income increased 72.8%
Operating income changed +72.8% from the comparable as-filed period.
$378.0M→$653.0M2 prior comparisons
Net income increased 30.0%
Net income changed +30.0% from the comparable as-filed period.
$514.0M→$668.0M2 prior comparisons
Revenue increased 21.9%
Revenue changed +21.9% from the comparable as-filed period.
$9.1B→$11.1B2 prior comparisons
Current liabilities increased 65.4%
Current liabilities changed +65.4% from the comparable as-filed period.
$33.8B→$55.8B3 prior comparisons
Current assets increased 36.7%
Current assets changed +36.7% from the comparable as-filed period.
$34.7B→$47.4B3 prior comparisons
Total assets increased 52.2%
Total assets changed +52.2% from the comparable as-filed period.
$53.1B→$80.8B3 prior comparisons
Free-cash-flow proxy changed across a low base
Free-cash-flow proxy changed +2532.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
$194.0M→$5.1B3 prior comparisons
Operating margin moved 173 bp higher
Operating margin changed +173 basis points from the comparable as-filed period.
4.15%→5.88%2 prior comparisons
Inventory increased 29.2%
Inventory changed +29.2% from the comparable as-filed period.
$9.8B→$12.7B3 prior comparisons
Operating cash flow changed across a low base
Operating cash flow changed +1396.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
$367.0M→$5.5B3 prior comparisons
Inventory / revenue moved 646 bp higher
Inventory / revenue changed +646 basis points from the comparable as-filed period.
107.84%→114.30%2 prior comparisons
Capital expenditure increased 123.1%
Capital expenditure changed +123.1% from the comparable as-filed period.
$173.0M→$386.0M3 prior comparisons
Gross profit increased 27.8%
Gross profit changed +27.8% from the comparable as-filed period.
$1.8B→$2.4B2 prior comparisons
Gross margin moved 99 bp higher
Gross margin changed +99 basis points from the comparable as-filed period.
20.26%→21.25%2 prior comparisons
Cost of revenue increased 20.3%
Cost of revenue changed +20.3% from the comparable as-filed period.
$7.3B→$8.7B2 prior comparisons
Operating cash-flow margin moved 4543 bp higher
Operating cash-flow margin changed +4543 basis points from the comparable as-filed period.
4.03%→49.46%2 prior comparisons
Free-cash-flow margin moved 4385 bp higher
Free-cash-flow margin changed +4385 basis points from the comparable as-filed period.
2.13%→45.98%2 prior comparisons
Working capital / assets moved 1218 bp lower
Working capital / assets changed -1218 basis points from the comparable as-filed period.
1.79%→-10.39%3 prior comparisons
Capex / revenue moved 158 bp higher
Capex / revenue changed +158 basis points from the comparable as-filed period.
1.90%→3.48%2 prior comparisons
Shares outstanding decreased 2.2%
Shares outstanding changed -2.2% from the comparable as-filed period. The change ranks at the 80th percentile of 5 prior comparable changes.
272,223,940→266,333,5815 prior comparisons
Research & development increased 18.4%
Research & development changed +18.4% from the comparable as-filed period.
$282.0M→$334.0M2 prior comparisons
Working capital changed across a sign change
Working capital changed -985.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$948.0M→-$8.4B3 prior comparisons
Current ratio decreased 17.4%
Current ratio changed -17.4% from the comparable as-filed period.
1.03→0.853 prior comparisons
Selling, general & administrative increased 15.8%
Selling, general & administrative changed +15.8% from the comparable as-filed period.
$1.2B→$1.4B2 prior comparisons
Operating cash flow / net income changed across a low base
Operating cash flow / net income changed +1051.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
0.71→8.221 prior comparisons
R&D / revenue moved 9 bp lower
R&D / revenue changed -9 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
3.10%→3.01%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.